<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>External cephalic version</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">External cephalic version</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">External cephalic version</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">G Justus Hofmeyr, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alana Chakrabarti, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 26, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4031039170"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>External cephalic version (ECV) refers to a procedure in which the fetus is rotated from a noncephalic to a cephalic presentation by manipulation through the mother's abdomen  (<a class="graphic graphic_figure graphicRef63535" href="/z/d/graphic/63535.html" rel="external">figure 1</a>). It is typically performed as an elective procedure in nonlaboring patients at or near term to improve their chances of having a vaginal cephalic birth. The success of ECV is influenced by both maternal and fetal factors. </p><p>This topic will discuss the procedure for ECV. The causes, diagnosis, management, and outcome of breech presentation are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6776.html" rel="external">"Overview of breech presentation"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Outcomes of ECV include the ability to turn a fetus from breech to cephalic presentation (ie, success rate), and the proportion of fetuses that remain in cephalic presentation at birth which affects the frequency of cesarean birth.</p><p class="headingAnchor" id="H556825689"><span class="h2">Version to cephalic presentation</span><span class="headingEndMark"> — </span>Success rates of ECV vary widely, ranging from as low as 22 percent to as high as 76 percent [<a href="#rid1">1-5</a>]. In a meta-analysis of 84 studies including almost 13,000 version attempts at term, the pooled success rate was 58 percent [<a href="#rid1">1</a>]. </p><p>After successful ECV, reversion to breech presentation occurs in a small subset of patients. For example, in one study of 2614 ECV attempts, 2.2 percent of successfully verted cases reverted to breech [<a href="#rid2">2</a>]. In addition, a small subset of patients with unsuccessful ECV have spontaneous version to a cephalic presentation. In the same study, 4.3 percent of patients with an unsuccessful ECV attempt subsequently had spontaneous cephalic version [<a href="#rid2">2</a>]. </p><p>The success of ECV is influenced by both maternal and fetal factors, as discussed in the following sections.</p><p class="headingAnchor" id="H2601208071"><span class="h3">Factors that impede success</span><span class="headingEndMark"> — </span>Factors that may be associated with lower ECV success rates include:</p><p class="bulletIndent1"><span class="glyph">●</span>Anterior [<a href="#rid4">4,6-10</a>], lateral [<a href="#rid11">11</a>], or cornual placenta [<a href="#rid11">11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased amniotic fluid volume [<a href="#rid8">8-10,12-14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Descent of the breech into the pelvis [<a href="#rid9">9,13,15,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Female sex [<a href="#rid5">5</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal head not palpable [<a href="#rid9">9,15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Firm maternal abdominal muscles [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Frank breech presentation [<a href="#rid8">8,18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low birth weight [<a href="#rid5">5,10,12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nulliparity [<a href="#rid4">4-9,12,15,19-21</a>]. In the series including 2614 ECV attempts discussed above (see <a class="local">'Version to cephalic presentation'</a> above), nulliparous compared with parous patients had lower rates of ECV success (40 versus 64 percent) [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obesity [<a href="#rid5">5,8,13,15,22</a>]. In one large series, patients with a body mass index (BMI ≥40 kg/m<sup>2</sup>) compared with normal BMI had a lower ECV success rate (59 versus 65 percent); of those patients, vaginal birth rates were also lower (60 versus 81 percent) [<a href="#rid22">22</a>]. However, one large study found no effect [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Persistent breech presentation (ie, breech presentation confirmed during every ultrasound examination from midpregnancy onward) [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posteriorly located fetal spine [<a href="#rid13">13,18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tense uterus [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thinner myometrial thickness [<a href="#rid25">25</a>].</p><p></p><p>Some of these factors may also impede spontaneous version [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H4113304121"><span class="h3">Factors that enhance success</span><span class="headingEndMark"> — </span>In addition to absence of the above unfavorable prognostic factors, favorable prognostic factors may include [<a href="#rid27">27-30</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Amniotic fluid index &gt;10 cm [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complete breech position [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonlongitudinal lie – A fetus in oblique or transverse lie is easier to rotate to a cephalic lie than the breech fetus since only small degrees of rotation are needed and these lies are inherently unstable. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior placental location [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provider experienced in ECV and/or use of a standard ECV protocol – In one cohort study, introduction of a dedicated ECV team increased the overall success rate from 40 to 70 percent; lower rates were reported in nulliparous patients (24 to 59 percent) [<a href="#rid29">29</a>]. Similarly, in another cohort study, implementation of a standardized protocol for ECV was associated with an increase in the success rate (47 percent [110/236 pregnant patients] to 61 percent [85/139 pregnant patients]) [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unengaged presenting part – In one retrospective study, sonographic measurement of the forebag (ie, distance from the internal cervical os to the presenting part) was an objective method for interpreting the degree of engagement and was predictive of ECV success [<a href="#rid33">33</a>]. In this study, a forebag &gt;1 cm was highly predictive of successful ECV, whereas a forebag &lt;1 cm was more likely to be associated with unsuccessful ECV, especially in nulliparous patients; all ECV procedures were performed by a single experienced physician.</p><p></p><p class="headingAnchor" id="H1231578843"><span class="h3">Unlikely or controversial factors</span></p><p class="bulletIndent1"><span class="glyph">●</span>Larger fetuses – There is no evidence to support avoiding ECV of fetuses who exceed any estimated fetal weight, as long as a trial of labor and vaginal birth is planned [<a href="#rid34">34</a>]. In a retrospective study, neither ultrasound-estimated fetal weight, nor birth weight when birth occurred within a week of the procedure, was associated with ECV success [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nuchal cord – While the author performs ECV in some settings of known nuchal cord (eg, single nuchal cord with a loose section of cord visible on ultrasound), there are sparse data on the risk of ECV in the presence of one or more nuchal cords [<a href="#rid35">35,36</a>], no guidelines for managing ECV in these pregnancies, and some clinicians do not perform ECV if a nuchal cord is present. </p><p></p><p class="bulletIndent1">One of the reasons for routine fetal heart rate monitoring during and following ECV is to detect fetal heart rate changes associated with cord entanglement or compression. Serious fetal heart rate abnormalities during ECV, such as prolonged bradycardia, are uncommon [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/14181.html" rel="external">"Nuchal cord", section on 'Breech presenting fetus'</a>.)</p><p></p><p class="bulletIndent1">Nuchal cords are a common finding on prenatal ultrasound and are not routinely reported in ultrasound reports since they can be considered a normal finding. This is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/14181.html" rel="external">"Nuchal cord"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with HIV – Although there is a theoretical risk of maternal to fetal HIV transmission in HIV-infected patients who undergo ECV, the risk is likely very small and compares favorably with the risk of vaginal breech birth (if cesarean birth is not planned) [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prior low transverse cesarean birth – Prior low transverse cesarean birth is not a contraindication to ECV; however, there is only limited evidence that it is safe in this population. The American College of Obstetricians and Gynecologists states that, if an attempt at vaginal birth is clinically appropriate, then decision making regarding ECV needs to be individualized [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1">Patients with a history of prior low transverse cesarean birth compared with those without appear to have similar ECV success rates [<a href="#rid40">40,41</a>] but lower rates of vaginal birth after a successful ECV. In a meta-analysis of six cohort and two case-control studies including over 14,500 patients, the overall success rate of ECV was similar between patients with and without a previous cesarean birth (range 63 to 83 percent); however, the rate of vaginal birth after successful ECV was lower (mean point prevalence 75 versus 92 percent, pooled odds ratio 0.26, 95% CI 0.14-0.5) [<a href="#rid42">42</a>]. Adverse maternal and perinatal events were rare and comparable between groups; no uterine ruptures were reported. A subsequent systematic review showed similar findings [<a href="#rid43">43</a>].</p><p></p><p class="headingAnchor" id="H747005319"><span class="h2">Impact on cesarean birth rate</span><span class="headingEndMark"> — </span>ECV decreases the frequency of cesarean birth compared with no ECV. In a meta-analysis of nine studies (three randomized trials and six cohort studies) including &gt;180,000 participants with breech fetuses, patients undergoing attempted ECV had a lower risk of cesarean birth compared with those who did not undergo attempted ECV (43 versus 75 percent; relative risk [RR] 0.57, 95% CI 0.5-0.64) [<a href="#rid44">44</a>]. A separate meta-analysis of eight randomized trials including 1308 patients reported similar findings (risk ratio [RR] 0.57, 95% CI 0.40-0.82) [<a href="#rid45">45</a>]. In another study that included 2614 ECV attempts, the cesarean birth rate was 55 percent (16 percent among those with successful ECV and 93 percent among those with unsuccessful ECV) [<a href="#rid2">2</a>]. It should be noted that there is considerable variability in cesarean birth rates in different settings depending on local practices of allowing vaginal breech birth. For example, cesarean birth rates are higher in studies performed in the United States and other countries where vaginal breech birth is uncommon (eg, Europe, Canada, Australia, New Zealand) and lower in countries where vaginal breech is more common (eg, India, Sudan, Zimbabwe, South Africa) [<a href="#rid44">44,45</a>]. </p><p>However, the cesarean birth rate after successful ECV remains higher than in the general obstetric population. In a meta-analysis of observational studies evaluating mode of birth, patients with a successful ECV compared with a cephalic-presenting fetus and no ECV had an approximately two-fold higher rate of cesarean birth (21 versus 11 percent, RR 2.19, 95% CI 1.73-2.76) [<a href="#rid46">46</a>]. The excess risk of cesarean birth was due to both dystocia and nonreassuring fetal heart rate patterns. There is no clear explanation for the increased frequency of dystocia after successful ECV. One theory is that factors common to both breech presentation and successful ECV, such as an unengaged presenting part or small maternal pelvis, are also risk factors for dystocia. Parity also plays a role in risk of dystocia. Multiparous patients are more likely than nulliparas to give birth vaginally after successful ECV [<a href="#rid47">47,48</a>].</p><p>By contrast, rates of cesarean birth appear to be similar for those with a fetus in cephalic presentation after ECV compared with spontaneous version. In a secondary analysis of a randomized trial, patients with a cephalic-presenting fetuses at birth as a result of successful ECV versus cephalic presenting fetuses who spontaneously turned from breech presentation in the third trimester had similar rates of cesarean birth [<a href="#rid49">49</a>].</p><p>ECV has also been reported to be cost-effective in studies from the United States and United Kingdom [<a href="#rid50">50,51</a>]. In one such study, ECV was cost-effective when compared with a scheduled cesarean birth for breech presentation when the probability of successful ECV was greater than 32 percent [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H4"><span class="h1">RISKS</span><span class="headingEndMark"> — </span>Risks associated with ECV are infrequent but include stillbirth, abruption, and emergency cesarean birth. </p><p>These risks must be weighed against the risks associated with:</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent breech presentation, including cord prolapse, probable cesarean birth, and complications of breech birth (whether vaginal or cesarean).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Planned cesarean birth, including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Precipitous labor leading to unplanned vaginal breech birth.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maternal risks (eg, surgical site infection, surgical injury, hemorrhage).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal/neonatal risks (eg, laceration during hysterotomy, transient tachypnea of the newborn, admission to high care unit, immune sequelae probably related to microbiome disturbance due to lack of exposure to vaginal flora [<a href="#rid52">52</a>]). An increased risk for development of childhood medical illnesses (eg, asthma, laryngitis, gastroenteritis, ulcerative colitis, celiac disease, lower respiratory tract infection, juvenile idiopathic arthritis) and reduced brain maturation have also been described [<a href="#rid53">53-55</a>]. (See  <a class="medical medical_review" href="/z/d/html/4459.html" rel="external">"Cesarean birth: Postoperative care, complications, and long-term sequelae"</a>.)</p><p></p><p>Risks of ECV were reported in a systematic review of 84 observation studies and randomized trials including 12,955 patients undergoing ECV after 36 weeks and included the following [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Overall complications – The pooled overall complication rate was 6.1 percent (95% CI 4.7-7.8) and included abnormal fetal heart rate changes, fetomaternal transfusion, vaginal bleeding, emergency cesarean birth, rupture of membranes, stillbirth, abruption, and cord prolapse. The overall complication rate is comparable to that of other large series [<a href="#rid56">56,57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stillbirth – The pooled risk of fetal death was 0.19 percent (95% CI 0.12-0.27), or 1 in 5000 ECV attempts. Only 2 of the 12 deaths were attributed to ECV; the remainder were unrelated or unexplained.</p><p></p><p class="bulletIndent1">In a subsequent systematic review of randomized trials, perinatal death occurred in 2 of 644 infants in the attempted ECV group and 6 of 661 infants in the group of breeches that did not undergo ECV (relative risk [RR] of perinatal death 0.39, 95% CI 0.09-1.64) [<a href="#rid45">45</a>]. The corrected perinatal mortality in a cohort of 2614 ECV attempts was 0.12 percent [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abruption – The pooled risk of abruption was 0.18 percent (95% CI 0.12-0.26), or 1 in 1200 ECV attempts.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Emergency cesarean birth – Emergency cesarean birth was performed in 49 cases; the pooled risk of emergency cesarean birth was 0.35 percent (95% CI 0.26-0.47), or 1 in 286 ECV attempts.</p><p></p><p>There was no definite correlation between the risk of complications and whether or not the ECV was successful. There were also several limitations to this analysis. For example, there were differences among studies in design, patient populations, ECV techniques, and ascertainment/definition of outcomes. Since many studies did not determine relevant outcomes among patients with breech presentation who did not undergo ECV, a reliable comparison of the risk of ECV versus expectant management could not be performed. In addition, there was no assessment of maternal satisfaction, including degree of discomfort and, possibly, negative psychological effects in the event of failure [<a href="#rid1">1,58-60</a>]. </p><p class="headingAnchor" id="H4005219282"><span class="h1">CANDIDATES</span></p><p class="headingAnchor" id="H3983328498"><span class="h2">Patients with confirmed breech</span><span class="headingEndMark"> — </span>ECV is offered to most patients with a noncephalic fetal lie. While the factors noted above may affect the success rate, it can be very difficult to predict success or failure in an individual case. Thus, it is reasonable to offer ECV to patients without contraindications. (See <a class="local">'Factors that impede success'</a> above and <a class="local">'Factors that enhance success'</a> above and <a class="local">'Potential contraindications'</a> below.)</p><p>Patients most likely to opt for ECV are those who are well-informed, encouraged to undergo the procedure, believe in its safety, and desire a vaginal birth [<a href="#rid61">61</a>]. Patients may choose not to undergo ECV because of fear of the procedure, incomplete information, and preference for planned cesarean birth.</p><p>Detection of breech presentation on physical examination, however, is imperfect and ultrasound examination improves detection of breech presentation. In one prospective study, 54 percent of breech presentations were unsuspected on clinical examination prior to ultrasound examination at 36 weeks gestation [<a href="#rid62">62</a>]. In another cohort study, introduction of routine ultrasound examination at 36 weeks reduced the rate of undiagnosed breech before labor from 22.3 to 4.7 percent (relative risk 0.21, 95% CI 0.12-0.36) [<a href="#rid63">63</a>].</p><p class="headingAnchor" id="H1983971645"><span class="h2">Potential contraindications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Absolute contraindications</strong> – Any absolute contraindication to labor and vaginal birth, regardless of fetal presentation, is an absolute contraindication to ECV; examples include placenta previa and previous classical cesarean birth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Relative contraindications</strong> – There is no consensus about other contraindications to ECV and no strong evidence on which to base recommendations [<a href="#rid64">64</a>]. Based primarily on expert opinion, ECV is generally contraindicated in the following settings because they are associated with a low likelihood of successful version and/or increased risk of fetal harm from the procedure:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fetal growth restriction</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hyperextended fetal head</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple gestation – In a systematic review including 23 cases of attempted ECV for a noncephalic-presenting twin, the ECV success rate was 57 percent and the vaginal birth rate was 48 percent [<a href="#rid65">65</a>]. In a subsequent prospective study including twin gestations, ECV of twin A was successful in 10/18 (56 percent) of cases [<a href="#rid66">66</a>]. Additional randomized trials are needed to assess the safety and efficacy of ECV for the presenting twin.</p><p></p><p class="bulletIndent2">Acceptable approaches for the management of a second twin in breech presentation include ECV and breech extraction; breech extraction compared with ECV may be associated with a higher successful vaginal birth rate [<a href="#rid67">67</a>]. (See  <a class="medical medical_review" href="/z/d/html/4467.html" rel="external">"Twin pregnancy: Labor and delivery", section on 'Approach to cephalic/noncephalic presentation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonreassuring fetal monitoring test results</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Placental abruption</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Previous vertical lower uterine segment cesarean birth</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ruptured membranes </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe oligohydramnios</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Significant fetal or uterine anomaly (eg, hydrocephaly, septate uterus).</p><p></p><p class="headingAnchor" id="H2889222376"><span class="h1">TIMING</span><span class="headingEndMark"> — </span>For most patients with breech fetuses who have no contraindications to the procedure, we offer ECV any time after 36 0/7 weeks of gestation but typically perform the procedure at 37 weeks of gestation. This approach takes advantage of the higher probability of turning the fetus before term, that the fetus will remain cephalic, and that the fetus is mature or nearly mature in the event of complications necessitating urgent cesarean birth [<a href="#rid68">68,69</a>]. Our approach is consistent with expert guidelines: The American College of Obstetricians and Gynecologists (ACOG) recommends discussing ECV at ≥36 0/7 weeks and performing the procedure at ≥37 0/7 weeks [<a href="#rid39">39</a>]; the Royal College of Obstetricians and Gynaecologists (RCOG) recommends offering ECV from 37 0/7 weeks, but states ECV may be offered to nulliparas at 36 0/7 weeks [<a href="#rid70">70</a>]. </p><p>ECV at earlier gestations (eg, 34 0/7 to 35 6/7 weeks) has a higher success rate than term ECV, but this advantage needs to be weighed against the possibility of delivering a preterm infant (due to an ECV-related complication) and lack of convincing evidence of a substantial reduction in cesarean birth with early versus term ECV. </p><p>ECV at later gestations (eg, 39 0/7) may be performed for patients with a fetus in a nonlongitudinal lie (ie, transverse, oblique). (See <a class="local">'Nonlongitudinal lies'</a> below.) </p><p>In a meta-analysis of three trials including 1906 participants, early compared with term ECV reduced the rate of noncephalic presentation at birth (42 versus 52 percent; risk ratio [RR] 0.81, 95% CI 0.74-0.9) [<a href="#rid71">71</a>]. While the cesarean birth rate was also lower in the early ECV group, the difference was modest and had borderline statistical significance (52 versus 56 percent; RR 0.92, 95% CI 0.85-1). Reasons for the lack of a clear impact on the cesarean birth rate include the possibility that fetuses in noncephalic presentation in the third trimester have characteristics that place them at higher risk of having antepartum/intrapartum complications necessitating cesarean birth even if they turn or are turned to cephalic presentation, and a willingness among European hospitals to deliver the term, but not preterm, breech fetus vaginally.</p><p>The largest trial in the meta-analysis included over 1500 patients with singleton breech fetuses who were randomly assigned to early (34 0/7 to 35 6/7 weeks) or term (≥37 weeks) ECV [<a href="#rid72">72</a>]. Nearly all procedures were performed by experienced practitioners; repeated ECV attempts were permitted, as was use of tocolytics and neuraxial anesthesia. Patients in the early ECV group had a lower risk of noncephalic fetal presentation at birth (41 versus 49 percent, relative risk [RR] 0.84, 95% CI 0.75-0.94). The procedure was also slightly less painful at earlier gestations, but the difference was probably not clinically significant. Rates of cesarean birth between groups were similar (52 versus 56; RR 0.93, 95% CI 0.85-1.02). Rates of preterm birth before 37 weeks and median gestational age at birth (39.1 weeks) were also similar between groups. Complications during the procedure occurred in 3 to 4 percent of patients in each group; the most common complication was a nonreassuring fetal heart rate tracing.</p><p class="headingAnchor" id="H3110305560"><span class="h1">ALTERNATIVES</span><span class="headingEndMark"> — </span>Alternatives to ECV include expectant management, postural maneuvers to facilitate spontaneous version, moxibustion, and acupuncture.</p><p class="headingAnchor" id="H3215140416"><span class="h2">Expectant management</span><span class="headingEndMark"> — </span>Options for expectant management include planned cesarean birth (scheduled or unscheduled) of a persistently breech fetus or a trial of labor of a persistently breech fetus. (See  <a class="medical medical_review" href="/z/d/html/6776.html" rel="external">"Overview of breech presentation", section on 'Approach to management at or near term'</a>.)</p><p>Since spontaneous version may occur at any time, even after a failed ECV, a case can be made for delaying cesarean birth for breech presentation until late pregnancy or early labor. Risks associated with delaying cesarean birth include potential complications of persistent breech presentation (eg, cord prolapse, precipitous labor if membranes rupture) and increased risk of maternal infection when cesarean birth is performed intrapartum versus prepartum.</p><p>There are insufficient data to balance the potential benefits and risks of expectant management, but risks are probably low for most patients.</p><p class="headingAnchor" id="H1345601544"><span class="h2">Postural maneuvers to facilitate spontaneous version</span><span class="headingEndMark"> — </span>There are insufficient data to recommend for or against the use of postural maneuvers (eg, pelvic elevation using a knee-chest position with or without a full bladder [<a href="#rid73">73,74</a>], supine head-down position with the pelvis supported by a wedge-shaped cushion [<a href="#rid75">75</a>], lateral position on the side opposite the fetal back [<a href="#rid76">76</a>]) for version of the nonvertex fetus, but these maneuvers are unlikely to be harmful. By contrast, home-based rebozo exercises appear to have a negative effect and may decrease the rate of cephalic presentation at birth [<a href="#rid77">77</a>].</p><p>High quality evidence that maternal postural changes facilitate spontaneous version are lacking. In a systematic review of six randomized and quasi-randomized trials including 417 patients, maternal postural management compared with no intervention resulted in a similar rate of noncephalic births [<a href="#rid78">78</a>]. </p><p class="headingAnchor" id="H4088708207"><span class="h2">Moxibustion and acupuncture</span><span class="headingEndMark"> — </span>There are insufficient data to recommend for or against the use of Moxibustion, a Chinese herb, that when burnt close to the skin of the tip of the fifth toe (acupuncture point Bladder 67 [BL67], Chinese name Zhiyin), has been proposed as a means of correcting breech presentation. It can be used alone or with acupuncture. The procedure is performed for 20 to 60 minutes, once or twice per day, two to seven times per week for one to two weeks.</p><p>In a systematic review of randomized and quasi-randomized trials including subjects with a singleton breech fetus, moxibustion compared with no moxibustion resulted in lower rates of noncephalic presentation at birth (risk ratio [RR] 0.87, 95% CI 0.78 to 0.99; seven trials, 1152 patients) [<a href="#rid79">79</a>]. However, rates of cesarean birth were similar between groups (six trials, 1030 subjects). Adverse events may include abdominal pain, nausea, an unpleasant odor which can cause respiratory irritation, and burns. </p><p class="headingAnchor" id="H539557755"><span class="h1">PREPROCEDURE</span></p><p class="headingAnchor" id="H2397538399"><span class="h2">Ultrasound examination</span><span class="headingEndMark"> — </span>Prior to performing ECV, an ultrasound examination is performed to confirm fetal and placental position (placenta previa is a contraindication to vaginal birth) and to look for factors which can reduce the likelihood of success (eg, oligohydramnios, significant fetal or uterine anomalies) which may warrant not proceeding with ECV. (See <a class="local">'Factors that impede success'</a> above and <a class="local">'Potential contraindications'</a> above.)</p><p class="headingAnchor" id="H1582255270"><span class="h2">Assessment of fetal well-being</span><span class="headingEndMark"> — </span>Fetal well-being is documented with a reactive fetal heart rate pattern or satisfactory biophysical profile score before exposing the fetus to a potentially stressful procedure. In low-resource settings without access to ultrasound or fetal heart rate monitoring, fetal well-being may be confirmed based on a report of good fetal movements or a positive clinical fetal acoustic stimulation test and probably outweighs the risks of no ECV attempt.</p><p class="headingAnchor" id="H3030134034"><span class="h2">Counseling</span><span class="headingEndMark"> — </span>Patients are informed of the relative advantages and disadvantages of ECV in order to make an informed decision. This choice is likely to be influenced by the value the patient places on a vaginal cephalic birth. In addition to a description of the procedure, some of the elements of informed consent include a discussion of:</p><p class="bulletIndent1"><span class="glyph">●</span>Why the procedure is being performed (if ECV is successful, the patient is likely to avoid cesarean birth performed because of breech presentation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alternatives to ECV. (See <a class="local">'Alternatives'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Overall success rate; all patients should be informed of the possibility of failure, whether or not risk factors for failure are present. (See <a class="local">'Outcomes'</a> above and <a class="local">'Factors that impede success'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The small chance that the fetus will spontaneously revert to breech. (See <a class="local">'Version to cephalic presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risks. (See <a class="local">'Risks'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Procedure-related discomfort.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Side effects of any medications that may be administered.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management plans if the procedure is successful or unsuccessful (eg, amniotomy and induction, scheduled cesarean birth, second attempt at ECV).</p><p></p><p>Counseling is more effective and patient satisfaction is higher if a structured decision aid for patients with breech presentation is used [<a href="#rid80">80,81</a>].</p><p class="headingAnchor" id="H2300875425"><span class="h2">Oral intake</span><span class="headingEndMark"> — </span>Given the low complication rate, we and others believe intravenous (IV) access and avoidance of oral intake before the procedure are unnecessary [<a href="#rid82">82</a>]. In fact, we actually encourage increased oral fluid intake for 24 hours prior to ECV attempt as this may increase amniotic fluid volume, though not proven to increase ECV success rate. (See <a class="local">'Other'</a> below.)</p><p>However, some practice guidelines recommend a two-hour oral restriction [<a href="#rid83">83</a>], and other providers place an IV catheter and restrict oral intake for four to 8 hours before the procedure in case emergency cesarean birth becomes necessary [<a href="#rid84">84</a>]. </p><p class="headingAnchor" id="H14"><span class="h1">PROCEDURE</span><span class="headingEndMark"> — </span>The procedure should be performed by an experienced operator in a facility with ready access to emergency cesarean birth. </p><p>A video of the author performing an ECV can be found here  (<a class="graphic graphic_movie graphicRef141647" href="/z/d/graphic/141647.html" rel="external">movie 1</a>).</p><p>Video recordings of the ECV technique have also been published in the WHO Reproductive Health Library [<a href="#rid85">85</a>] and in the Journal of Visualized Experiments (JoVE) [<a href="#rid86">86</a>]. A video recording of a two-operator technique is available online [<a href="#rid87">87</a>]. Simulation training models have been developed [<a href="#rid88">88,89</a>], and various modifications of the technique have been reported [<a href="#rid90">90</a>].</p><p class="headingAnchor" id="H2578323859"><span class="h2">Technique</span><span class="headingEndMark"> — </span>Various techniques have been reported but have not been compared in randomized trials [<a href="#rid91">91</a>]. Our technique is described here and in the algorithm  (<a class="graphic graphic_algorithm graphicRef100240" href="/z/d/graphic/100240.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Each step of the procedure is explained to the patient. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient is positioned on a narrow, firm examination table with the fetal back towards the operator. A wedge or cushion can be used to tilt the uterus towards the operator and minimize aortocaval compression.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tocolysis is administered in most patients. (See <a class="local">'Tocolysis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients are asked to keep their abdominal muscles relaxed and inform the operator if they feel any discomfort, rather than tensing their abdominal muscles, so that the pressure being used can be modified. Good rapport with patients is essential to help them relax and keep them from tensing their muscles, which makes it more difficult to manipulate the fetus.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ultrasound coupling gel or powder (eg, cornstarch) is applied to the patient's abdomen to help the operator's hands slide over the skin while manipulating the fetus. Ultrasound coupling gel is typically used when the fetal heart rate is monitored by ultrasound rather than by intermittent auscultation. In a randomized trial, aqueous gel was more effective than powder for reducing maternal pain [<a href="#rid92">92</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The breech is disengaged from the pelvis by slowly inserting the fingertips of both hands deeply behind the symphysis pubis to scoop the breech from the pelvis to a position above the sacral promontory. Some obstetricians prefer to use two operators, one manipulating the breech and the other the fetal head.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The author prefers to begin with a backward somersault, whereas ACOG describes beginning with a forward roll and then attempting a backward roll if the forward roll fails [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Backward somersault</strong> – For the fetus in the left sacrolateral position with planned backward somersault  (<a class="graphic graphic_figure graphicRef99955" href="/z/d/graphic/99955.html" rel="external">figure 2</a>), the operator stands on the patient's left side, on the same side as the fetal back. After disengagement from the pelvis as described above, the breech is held with the edge of the left palm and pushed toward the patient's right flank and upward. If the patient is steeply tilted on their side against a wall, the operator may sit and steady their left elbow on the examination table during the rest of the procedure.</p><p></p><p class="bulletIndent2">If version is not completed by this maneuver, the head is gently manipulated towards the patient's left flank and downward with the edge of the right hand, taking care to apply most pressure to the breech so that a flexed posture is maintained. Slight back-and-forth movement between the two hands may help promote fetal movement, but generally, pressure on the fetus should be slow and steady rather than repeated pushing.</p><p></p><p class="bulletIndent2">For the fetus in the right sacrolateral position, the operator stands on the patient's right side and uses the right to hand to elevate the breech towards the patient's left flank.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Forward somersault</strong> – For the fetus in the left sacrolateral position with planned forward somersault  (<a class="graphic graphic_figure graphicRef63535" href="/z/d/graphic/63535.html" rel="external">figure 1</a>), the operator is positioned on the right side of the patient, on the opposite side as the fetal back. The procedure is similar to that described above, except that once the breech has been disengaged from the pelvis, more pressure is applied to the head than the breech, to maintain flexion of the baby.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The fetal heart rate is auscultated every two minutes, with interruption of the procedure if bradycardia occurs. In one large series, an abnormal fetal heart rate leading to discontinuation of the ECV occurred in approximately 5 percent of cases [<a href="#rid93">93</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If ECV is unsuccessful after five minutes of attempts, we stop and let patients rest on their side for approximately two minutes before making another attempt, if they agree to it. We avoid making more than four attempts at one sitting.</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Role of ancillary measures to enhance success</span><span class="headingEndMark"> — </span>Several ancillary measures have been evaluated to look for ways to improve the success rate of ECV. The rationale for most of these interventions is to relax the uterus and/or anterior abdominal wall musculature and thereby enhance the operator's ability to manipulate the fetus. </p><p class="headingAnchor" id="H16"><span class="h3">Tocolysis</span><span class="headingEndMark"> — </span>For most patients, tocolysis is used prior to ECV; tocolysis appears to be the most studied and effective ancillary measure to relax the uterus and improve ECV success rates. Use of tocolysis may also increase the success of repeat ECV in patients who have undergone a previous unsuccessful attempt [<a href="#rid94">94</a>]. This approach is consistent with expert guidelines [<a href="#rid39">39,70,95</a>].</p><p>However, for patients in whom clinical assessment suggests that ECV is likely to be achieved easily, an initial attempt without tocolysis may be made. In our experience, this accounts for fewer than 20 percent of cases. Favorable clinical features include multiparity, easily palpable fetal parts, mobility of the fetus on palpation, and an unengaged presenting breech. (See <a class="local">'Factors that enhance success'</a> above.)</p><p class="headingAnchor" id="H2689243063"><span class="h4">Beta-adrenergic agonists</span><span class="headingEndMark"> — </span>When tocolysis is used, beta-adrenergic agonists are the preferred agent. One simple regimen is <a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">terbutaline</a> 0.25 mg subcutaneously 15 to 30 minutes prior to the procedure. Alternatively, salbutamol 0.1 mg in 20 mL <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> can be administered slowly intravenously (IV) immediately prior to the procedure; maternal heart rate is monitored during use. </p><p>In a systematic review of six randomized trials, ECV performed with versus without tocolysis with a parenteral beta-adrenergic agonist was associated with an increased prevalence of cephalic presentation in labor (average risk ratio [RR] 1.68, 95% CI 1.14-2.48) and a reduction in cesarean birth rates (average RR 0.77, 95% CI 0.67-0.88) in both nulliparous and multiparous patients [<a href="#rid96">96</a>]. </p><p class="headingAnchor" id="H2494671404"><span class="h4">Other tocolytics</span><span class="headingEndMark"> — </span>Information on other tocolytics (eg, atosiban [not available in the United States], <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">nifedipine</a>) are limited but suggest these agents are less effective than beta-adrenergic agonists.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atosiban</strong> – In a randomized trial including over 800 patients undergoing ECV, those treated with atosiban compared with fenoterol (a beta-adrenergic agonist not available in the United States) had lower rates of successful ECV (34 versus 40 percent, RR 0.73, 95% CI 0.55-0.93); rates of cephalic presentation at birth were similar between groups [<a href="#rid97">97</a>]. While the rate of cesarean birth was also similar, it trended higher in the atosiban group (60 versus 55 percent, RR 1.09, 95% CI 0.96-1.2).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> – IV nitroglycerin [<a href="#rid98">98,99</a>], or sublingual nitroglycerin spray [<a href="#rid100">100-102</a>], has also been evaluated for tocolysis.</p><p></p><p class="bulletIndent1">In a systematic review of randomized trials evaluating the use of <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> in pregnancy, nitroglycerine compared with placebo had similar effects on relaxing the uterus prior to ECV [<a href="#rid103">103</a>]. However, in a subsequent placebo-controlled trial, use of IV nitroglycerin appeared to increase ECV success in nulliparous, but not multiparous, patients [<a href="#rid104">104</a>].</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> has also been compared with beta-adrenergic agonists and appears to be less effective and associated with more side effects. In a randomized trial including 74 patients undergoing ECV, sublingual nitroglycerin (0.8 mg) compared with IV ritodrine (111 mcg/min) was associated with more side effects (eg, headache, fall in blood pressure) and fewer successful versions (25 versus 45 percent), although this was not statistically significant [<a href="#rid101">101</a>]. A retrospective study also reported that nitroglycerin was less effective than <a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">terbutaline</a> for patients undergoing ECV with neuraxial anesthesia [<a href="#rid105">105</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">Nifedipine</a> – In a systematic review including two trials evaluating tocolysis before ECV, nifedipine compared with <a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">terbutaline</a> or placebo did not increase the rate of successful version or lower the rate of cesarean birth [<a href="#rid106">106</a>].</p><p></p><p class="headingAnchor" id="H18"><span class="h4">Role of neuraxial anesthesia</span><span class="headingEndMark"> — </span>For most patients undergoing ECV, we do not use neuraxial anesthesia. While neuraxial anesthesia may be effective, it is invasive, can be costly [<a href="#rid107">107</a>], and most patients experience only mild discomfort. Helping the patient relax and reducing abdominal pressure may help reduce this discomfort. However, neuraxial anesthesia in combination with tocolysis is a reasonable option when ECV with tocolysis alone is unsuccessful, or at the time of planned cesarean birth when neuraxial anesthesia can be used for delivery (cesarean or vaginal). </p><p>Neuraxial anesthesia, in combination with tocolysis, can further increase ECV success rates. In a meta-analysis of nine randomized trials including 934 patients undergoing ECV with tocolysis, use of neuraxial anesthesia versus IV or no analgesia [<a href="#rid108">108</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased the ECV success rate by 44 percent (58.4 versus 43.1 percent, RR 1.44, 95% CI 1.27-1.64)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased the rate of cephalic presentation in labor by 37 percent (55.1 versus 40.2 percent, RR 1.37, 95% CI 1.08-1.73)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased the vaginal birth rate by 21 percent (54 versus 44.6 percent, RR 1.21, 95% CI 1.04-1.41)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reduced the cesarean birth rate by 17 percent (46 versus 55.3 percent, RR 0.83, 95% CI 0.71-0.97)</p><p></p><p>Although a theoretic risk of neuraxial anesthesia is that abolishing the mother's sensation may allow excessive use of force and thus increase the risk of complications, complication rates were similar in both groups.</p><p>The cost of neuraxial anesthesia for ECV may be offset by the reduced rate of cesarean birth after successful version [<a href="#rid109">109</a>].</p><p class="headingAnchor" id="H2738428751"><span class="h3">Other</span><span class="headingEndMark"> — </span>Other ancillary measures (eg, vibroacoustic stimulation, amnioinfusion, hydration, analgesia) have been proposed but data are limited.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vibroacoustic stimulation</strong> – Fetal vibroacoustic stimulation may improve ECV rates, but data are limited. Fetal vibroacoustic stimulation is used to stimulate a fetus in midline spine position to shift to a spine lateral position, which facilitates manipulating the fetus into a forward or backward roll. It is a reasonable ancillary measure as it is inexpensive, well-tolerated, and probably harmless; however, more data are needed to prove the efficacy of this approach.</p><p></p><p class="bulletIndent1">In one small crossover trial, patients exposed to fetal vibroacoustic stimulation compared with unexposed patients had higher rates of successful ECV (19 of 22 versus 1 of 12 patients); the rate of failed ECV was reduced with this intervention (RR 0.17, 95% CI 0.05-0.6) [<a href="#rid110">110</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amnioinfusion</strong> – Amnioinfusion does not appear to improve ECV success rates. Two small uncontrolled studies of amnioinfusion before ECV reported discordant results. In one study, six patients with failed ECV had a successful repeat attempt following transabdominal amnioinfusion with 700 to 900 mL warmed <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> [<a href="#rid111">111</a>]. By contrast, in a subsequent study, none of seven cases were successful [<a href="#rid112">112</a>]. A randomized trial was stopped early because of recruitment difficulties but did not report a higher rate of cephalic presentation at birth when amnioinfusion was performed before a second attempt at ECV [<a href="#rid113">113</a>]. (See  <a class="medical medical_review" href="/z/d/html/5383.html" rel="external">"Amnioinfusion", section on 'Transabdominal approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hydration</strong> – Preprocedure hydration does not appear to improve ECV success rates. In a prospective study, maternal IV infusion with 2 L of hypotonic <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> over two hours before ECV compared with no IV hydration increased amniotic fluid volume but did not result in higher ECV success rates [<a href="#rid114">114</a>]. Similarly, in a randomized trial, oral hydration with 2 L of water two hours before ECV compared with patients who did not receive the intervention increased amniotic fluid volume but did not result in a higher ECV success [<a href="#rid115">115</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Analgesia</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nitrous</strong> <strong>oxide</strong> – <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">Nitrous oxide</a> does not appear to improve ECV success rates. In a cohort study, inhalation of nitrous oxide (50 percent; 300 patients) compared with no analgesic reduced the proportion of patients who experienced severe pain during ECV, but did not affect other outcomes (eg, ECV success rate, rate of cesarean birth) [<a href="#rid116">116</a>]. Similarly, a small randomized trial [<a href="#rid117">117</a>] and a meta-analysis [<a href="#rid118">118</a>] found no benefit of inhaled nitrous oxide compared with oxygen placebo [<a href="#rid117">117</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">Remifentanil</a> – While remifentanil, an opioid, appears to improve rates of ECV (but not rates of cesarean birth), we do not use opioid analgesia for ECV in our practice. </p><p></p><p class="bulletIndent2">In a meta-analysis of four randomized trials including 482 patients undergoing ECV, <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> compared with placebo or no anesthesia increased ECV success rates (risk ratio [RR] 1.43; 95% CI 1.14-1.78) and reduced pain scores (mean difference -1.97; 95% CI -2.49 to -1.46); rates of cesarean birth were similar between groups [<a href="#rid119">119</a>]. Adverse events (eg, maternal hypotension, fetal bradycardia) were uncommon. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hypnosis</strong> – Hypnosis does not appear to be effective for pain relief during ECV [<a href="#rid120">120</a>], but may increase success rates as a result of maternal relaxation [<a href="#rid121">121</a>].</p><p></p><p class="headingAnchor" id="H22"><span class="h1">POSTPROCEDURE</span></p><p class="headingAnchor" id="H620039836"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>After ECV, fetal well-being is evaluated by cardiotocography. We monitor the fetal heart rate (FHR) until it is stable and reactive rather than for a minimum period of time. It is common for FHR tracings to be nonreactive for 20 to 40 minutes after ECV. These changes may reflect the fetal response to a transient period of stress caused by decreased uteroplacental blood flow during the procedure [<a href="#rid122">122</a>].</p><p>The association between FHR abnormalities and ECV varies in the literature. In two prospective studies in which ECV was successful in 51 and 60 percent of cases, changes in FHR were noted in 9 and 28 percent of ECV attempts [<a href="#rid123">123,124</a>]. Very few patients (5/1266) required emergency cesarean birth: three for FHR abnormalities and two for vaginal bleeding, likely related to abruption. Transient fetal bradycardia was more frequently noted after successful ECV compared with unsuccessful ECV (37 versus 27 percent), suggesting that successful ECV imposes greater stress on the fetus. The presence of transient fetal bradycardia did not affect perinatal outcomes, such as fetal distress during labor or rates of vaginal birth, in either study.</p><p class="headingAnchor" id="H620039752"><span class="h2">Anti-D-immune globulin</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9858" href="/z/d/drug information/9858.html" rel="external">Anti-D immune globulin</a> is administered to D-negative patients immediately after ECV; this is consistent with expert guidelines [<a href="#rid39">39,70</a>]. Given the extremely low risk of a large fetomaternal bleed, performing a Kleihauer-Betke or similar test to quantitate fetomaternal bleeding appears to be unnecessary before administration [<a href="#rid125">125</a>]. (See  <a class="medical medical_review" href="/z/d/html/6773.html" rel="external">"RhD alloimmunization: Prevention in pregnant and postpartum patients", section on 'Selective prophylaxis for pregnancy complications associated with fetomaternal bleeding'</a>.)</p><p>Fetomaternal hemorrhage is almost always less than 30 mL. In a prospective study including over 1200 patients with a negative Kleihauer-Betke test before ECV, conversion to a positive test after the procedure occurred in 2.4 percent of patients [<a href="#rid126">126</a>]. Of the 30 patients with a newly positive test, the majority (66 percent) had only rare fetal erythrocytes on the Kleihauer-Betke smear, 33 percent had an estimated bleed greater than 1 mL, and only 1 patient had an estimated bleed of 80 mL [<a href="#rid126">126</a>]. Risk factors for fetomaternal bleeding could not be identified. Others have also reported rare cases of massive fetomaternal hemorrhage [<a href="#rid127">127,128</a>].</p><p class="headingAnchor" id="H620039920"><span class="h2">Management after successful ECV</span><span class="headingEndMark"> — </span>Routine prenatal care is typically resumed after successful ECV. We agree with the American College of Obstetricians and Gynecologists to avoid immediate induction (also termed "stabilizing induction") in an attempt to minimize the chance of reversion [<a href="#rid39">39</a>], except in patients with other indications for induction of labor (eg, ≥39 weeks of gestation, unstable fetal lie [such as oblique or transverse lie, or repeated spontaneous change of lie]). In general, the rate of reversion to breech is small, while induction is associated with longer labors, increases the risk of neonatal morbidity if performed at &lt;39 weeks of gestation, may increase the risk of cesarean birth, and can be costly.</p><p>In a cohort study including 627 patients, factors that increased the risk of cesarean birth after successful version included labor induction, less than two weeks between ECV and delivery, high body mass index, and previous cesarean birth; the overall cesarean birth rate was 15 percent [<a href="#rid129">129</a>]. In another study including 301 successful ECV procedures, the cesarean birth rate was 13 percent and instrumental delivery rate was 6 percent [<a href="#rid130">130</a>]. Nulliparity was the only predictive factor for these birth outcomes.</p><p class="headingAnchor" id="H620039954"><span class="h2">Management after unsuccessful ECV</span><span class="headingEndMark"> — </span>If ECV for breech presentation is unsuccessful or the fetus reverts to breech, one or two retrials of version can be attempted in one or more days. We would not reattempt ECV after two unsuccessful attempts on separate days  (<a class="graphic graphic_algorithm graphicRef100240" href="/z/d/graphic/100240.html" rel="external">algorithm 1</a>).</p><p>Some breech-presenting fetuses will spontaneously turn. In one prospective study including 226 patients with a failed ECV attempt, the frequency of subsequent spontaneous cephalic version was 6.6 percent [<a href="#rid8">8</a>]. Spontaneous cephalic version was more likely in those who were multiparous compared with nulliparous (12.5 versus 2.3 percent) [<a href="#rid131">131</a>]. </p><p>Delivery of patients with persistent breech presentation is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6776.html" rel="external">"Overview of breech presentation"</a> and  <a class="medical medical_review" href="/z/d/html/5384.html" rel="external">"Delivery of the singleton fetus in breech presentation"</a>.)</p><p class="headingAnchor" id="H3832775754"><span class="h1">SPECIAL CONSIDERATIONS</span></p><p class="headingAnchor" id="H556289416"><span class="h2">Intrapartum ECV</span><span class="headingEndMark"> — </span>ECV appears to be a safe option for patients who present in labor with an unengaged breech presentation, intact membranes, normal amniotic fluid volume, and no contraindications to the procedure (see <a class="local">'Potential contraindications'</a> above). Small case series have reported successful intrapartum ECV in this setting [<a href="#rid13">13,132,133</a>]; tocolysis was used in some series. Available data are insufficient to determine whether intrapartum ECV is more or less successful than antepartum ECV.</p><p>Advantages of delaying ECV until labor begins are that the maximum time for spontaneous version has been provided, fetal condition can be monitored continuously from beginning of ECV to birth, cesarean birth can be performed expeditiously since the patient is already on the labor unit, and administration of <a class="drug drug_general" data-topicid="9858" href="/z/d/drug information/9858.html" rel="external">anti-D immune globulin</a> can be delayed until the neonate's blood type is known (and thus avoided if the neonate is D-negative).</p><p>The disadvantages of planned intrapartum ECV are that the opportunity to perform ECV may be lost due to descent of the breech into the pelvis, ruptured membranes, or rapid labor.</p><p class="headingAnchor" id="H1119333844"><span class="h2">Nonlongitudinal lies</span><span class="headingEndMark"> — </span>Because there is a tendency for nonlongitudinal lies (ie, transverse, oblique) to recur, we delay ECV in these pregnancies until early spontaneous labor or until labor induction is appropriate (usually 39 0/7 weeks gestation). After successful ECV in such patients, we perform amniotomy to stabilize the lie, and then induce labor.</p><p class="headingAnchor" id="H453364609"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109521.html" rel="external">"Society guideline links: Breech presentation and external cephalic version"</a>.) </p><p class="headingAnchor" id="H2229720458"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/140160.html" rel="external">"Patient education: External cephalic version (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>External cephalic version</strong> – External cephalic version (ECV) refers to a procedure in which the fetus is rotated from a noncephalic to a cephalic presentation by manipulation through the mother’s abdomen  (<a class="graphic graphic_figure graphicRef63535" href="/z/d/graphic/63535.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef99955" href="/z/d/graphic/99955.html" rel="external">figure 2</a>). The success of ECV varies and is influenced by both maternal and fetal factors and provider experience. (See <a class="local">'Introduction'</a> above and <a class="local">'Version to cephalic presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risks</strong> – There is a small risk of procedure-related complications which may include abnormal fetal heart rate changes, fetomaternal transfusion, vaginal bleeding, emergency cesarean birth, rupture of membranes, stillbirth, abruption, and cord prolapse. These risks must be weighed against the risks associated with persistent breech presentation, which include cord prolapse and risks associated with a planned cesarean birth and unplanned vaginal breech birth. (See <a class="local">'Risks'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Candidates</strong> – For most patients with breech presentation with no contraindications to labor and vaginal birth, we recommend ECV rather than expectant management (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). ECV increases the likelihood that the fetus will be in cephalic presentation at the onset of labor and decreases the frequency of cesarean birth. However, patients who have had a successful ECV are still at increased risk of cesarean birth compared with the general obstetric population. ECV is generally well tolerated and safe, though procedure-related complications may occur. (See <a class="local">'Candidates'</a> above and <a class="local">'Impact on cesarean birth rate'</a> above and <a class="local">'Risks'</a> above.)</p><p></p><p class="bulletIndent1">We avoid ECV in settings associated with a low likelihood of successful version or increased risk of fetal harm from the procedure. (See <a class="local">'Potential contraindications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients, we suggest performing ECV at ≥36 weeks of gestation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). The safety and efficacy of ECV at this gestational age are well established. ECV attempts can be initiated earlier (34 to 35 6/7 weeks) to improve the likelihood of success (ie, cephalic presentation at birth), though this approach has not been clearly shown to reduce cesarean birth compared with ECV later in pregnancy. ECV attempts may also be initiated later (39 0/7) if the fetus is in a nonlongitudinal lie (ie, transverse, oblique). (See <a class="local">'Timing'</a> above and <a class="local">'Nonlongitudinal lies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>ECV can be performed in early labor if membranes are intact and there are no contraindications. (See <a class="local">'Intrapartum ECV'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure</strong> – Our approach to ECV is illustrated by the algorithm  (<a class="graphic graphic_algorithm graphicRef100240" href="/z/d/graphic/100240.html" rel="external">algorithm 1</a>). (See <a class="local">'Technique'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Use of tocolysis</strong> – For most patients, we suggest treatment with a beta-adrenergic receptor agonist prior to ECV (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). This relaxes the uterus and increases the likelihood of ECV success. One simple regimen is <a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">terbutaline</a> 0.25 mg subcutaneously 15 to 30 minutes prior to the procedure. It is reasonable to omit the tocolytic agent in patients in whom clinical assessment suggests that ECV is likely to be achieved easily. (See <a class="local">'Tocolysis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of neuraxial anesthesia</strong> – For most patients, we suggest not routinely using neuraxial anesthesia for ECV (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). While neuraxial anesthesia may improve ECV success rates, it is invasive, can be costly, and most patients experience only mild discomfort. However, neuraxial anesthesia is a reasonable option when ECV with tocolysis alone is unsuccessful, or at the time of planned cesarean birth when neuraxial anesthesia can be used for delivery (cesarean or vaginal). (See <a class="local">'Role of neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postprocedure</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After ECV, we monitor the fetal heart rate until it is stable and reactive. It is common for fetal heart rate tracings to be nonreactive for 20 to 40 minutes after ECV. (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We administer <a class="drug drug_general" data-topicid="9858" href="/z/d/drug information/9858.html" rel="external">anti-D immune globulin</a> to RhD-negative patients who undergo ECV. (See <a class="local">'Anti-D-immune globulin'</a> above and  <a class="medical medical_review" href="/z/d/html/6773.html" rel="external">"RhD alloimmunization: Prevention in pregnant and postpartum patients", section on 'Indications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients, we do not perform an elective induction immediately after ECV for breech presentation. However, because there is a tendency for a nonlongitudinal (ie, transverse, oblique) lies to recur, after successful ECV of a nonlongitudinal lie, some clinicians perform amniotomy to stabilize the lie, and then induce labor. (See <a class="local">'Management after successful ECV'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the initial attempt at ECV is unsuccessful, we offer the patient a reattempt of the procedure in one or more days. After two unsuccessful attempts on separate days, we would not try again. (See <a class="local">'Management after unsuccessful ECV'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Grootscholten K, Kok M, Oei SG, et al. External cephalic version-related risks: a meta-analysis. Obstet Gynecol 2008; 112:1143.</a></li><li><a class="nounderline abstract_t">Melo P, Georgiou EX, Hedditch A, et al. External cephalic version at term: a cohort study of 18 years' experience. BJOG 2019; 126:493.</a></li><li><a class="nounderline abstract_t">Sium AF, Gudu W, Urgie T, Masresha G. External cephalic version success rate and associated factors: Experience from a tertiary center in Sub-Saharan Africa: A cross-sectional study. PLoS One 2023; 18:e0280404.</a></li><li><a class="nounderline abstract_t">Unno S, Ogawa K, Nukariya A, et al. Predictive factors for successful external cephalic version with regional anesthesia. J Obstet Gynaecol Res 2023; 49:1335.</a></li><li><a class="nounderline abstract_t">Londero AP, Xholli A, Massarotti C, et al. Factors influencing the effect of external cephalic version: a retrospective nationwide cohort analysis. Arch Gynecol Obstet 2023; 308:1127.</a></li><li><a class="nounderline abstract_t">Brocks V, Philipsen T, Secher NJ. A randomized trial of external cephalic version with tocolysis in late pregnancy. Br J Obstet Gynaecol 1984; 91:653.</a></li><li><a class="nounderline abstract_t">Rabinovici J, Barkai G, Shalev J, et al. Impact of a protocol for external cephalic version under tocolysis at term. Isr J Med Sci 1986; 22:34.</a></li><li><a class="nounderline abstract_t">Ben-Meir A, Erez Y, Sela HY, et al. Prognostic parameters for successful external cephalic version. J Matern Fetal Neonatal Med 2008; 21:660.</a></li><li><a class="nounderline abstract_t">López-Pérez R, Lorente-Fernández M, Velasco-Martínez M, Martínez-Cendán JP. Prediction model of success for external cephalic version. Complications and perinatal outcomes after a successful version. J Obstet Gynaecol Res 2020; 46:2002.</a></li><li><a class="nounderline abstract_t">Kirkinen P, Ylöstalo P. Ultrasonic examination before external version of breech presentation. Gynecol Obstet Invest 1982; 13:90.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ, Sadan O, Myer IG, et al. External cephalic version and spontaneous version rates: ethnic and other determinants. Br J Obstet Gynaecol 1986; 93:13.</a></li><li><a class="nounderline abstract_t">Ebner F, Friedl TW, Leinert E, et al. Predictors for a successful external cephalic version: a single centre experience. Arch Gynecol Obstet 2016; 293:749.</a></li><li><a class="nounderline abstract_t">Fortunato SJ, Mercer LJ, Guzick DS. External cephalic version with tocolysis: factors associated with success. Obstet Gynecol 1988; 72:59.</a></li><li><a class="nounderline abstract_t">Boucher M, Bujold E, Marquette GP, Vezina Y. The relationship between amniotic fluid index and successful external cephalic version: a 14-year experience. Am J Obstet Gynecol 2003; 189:751.</a></li><li><a class="nounderline abstract_t">Kok M, Cnossen J, Gravendeel L, et al. Clinical factors to predict the outcome of external cephalic version: a metaanalysis. Am J Obstet Gynecol 2008; 199:630.e1.</a></li><li><a class="nounderline abstract_t">Wise MR, Sadler L, Ansell D. Successful but limited use of external cephalic version in Auckland. Aust N Z J Obstet Gynaecol 2008; 48:467.</a></li><li><a class="nounderline abstract_t">Westgren M, Edvall H, Nordström L, et al. Spontaneous cephalic version of breech presentation in the last trimester. Br J Obstet Gynaecol 1985; 92:19.</a></li><li><a class="nounderline abstract_t">Donald WL, Barton JJ. Ultrasonography and external cephalic version at term. Am J Obstet Gynecol 1990; 162:1542.</a></li><li><a class="nounderline abstract_t">Pluta M, Schmidt S, Giffei JM, Saling E. Die Ausere wendung de Feten aus beckenendlage Schadellage in Terminnale unter Tokolyse. Z Geburtshilfe Perinatale 1981; 1985:207.</a></li><li><a class="nounderline abstract_t">Tan GW, Jen SW, Tan SL, Salmon YM. A prospective randomised controlled trial of external cephalic version comparing two methods of uterine tocolysis with a non-tocolysis group. Singapore Med J 1989; 30:155.</a></li><li><a class="nounderline abstract_t">Dyson DC, Ferguson JE 2nd, Hensleigh P. Antepartum external cephalic version under tocolysis. Obstet Gynecol 1986; 67:63.</a></li><li><a class="nounderline abstract_t">Chaudhary S, Contag S, Yao R. The impact of maternal body mass index on external cephalic version success. J Matern Fetal Neonatal Med 2019; 32:2159.</a></li><li><a class="nounderline abstract_t">Svensson E, Axelsson D, Nelson M, et al. Success rate of external cephalic version in relation to the woman's body mass index and other factors-a population-based cohort study. Acta Obstet Gynecol Scand 2021; 100:2260.</a></li><li><a class="nounderline abstract_t">Lauterbach R, Bachar G, Ben-David C, et al. Association of Persistent Breech Presentation With External Cephalic Version Success. Obstet Gynecol 2021; 137:258.</a></li><li><a class="nounderline abstract_t">Buhimschi CS, Buhimschi IA, Wehrum MJ, et al. Ultrasonographic evaluation of myometrial thickness and prediction of a successful external cephalic version. Obstet Gynecol 2011; 118:913.</a></li><li><a class="nounderline abstract_t">Lau TK, Lo KW, Wan D, Rogers MS. Predictors of successful external cephalic version at term: a prospective study. Br J Obstet Gynaecol 1997; 104:798.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ. Effect of external cephalic version in late pregnancy on breech presentation and caesarean section rate: a controlled trial. Br J Obstet Gynaecol 1983; 90:392.</a></li><li><a class="nounderline abstract_t">Mahomed K, Seeras R, Coulson R. External cephalic version at term. A randomized controlled trial using tocolysis. Br J Obstet Gynaecol 1991; 98:8.</a></li><li><a class="nounderline abstract_t">Thissen D, Swinkels P, Dullemond RC, van der Steeg JW. Introduction of a dedicated team increases the success rate of external cephalic version: A prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2019; 236:193.</a></li><li><a class="nounderline abstract_t">Naert MN, Kishkovich TP, Warsame F, et al. Role of individual physicians in success of external cephalic version. Am J Obstet Gynecol 2023; 229:347.</a></li><li><a class="nounderline abstract_t">Kok M, Cnossen J, Gravendeel L, et al. Ultrasound factors to predict the outcome of external cephalic version: a meta-analysis. Ultrasound Obstet Gynecol 2009; 33:76.</a></li><li><a class="nounderline abstract_t">Kuppens SM, Francois AM, Hasaart TH, et al. [Fewer breech deliveries after implementation of a modified cephalic version protocol]. Ned Tijdschr Geneeskd 2010; 154:A63.</a></li><li><a class="nounderline abstract_t">Isakov O, Reicher L, Lavie A, et al. Prediction of Success in External Cephalic Version for Breech Presentation at Term. Obstet Gynecol 2019; 133:857.</a></li><li><a class="nounderline abstract_t">Burgos J, Melchor JC, Cobos P, et al. Does fetal weight estimated by ultrasound really affect the success rate of external cephalic version? Acta Obstet Gynecol Scand 2009; 88:1101.</a></li><li><a class="nounderline abstract_t">Wong G, Ludmir J. OP11.02: Nuchal cords in breech presentation at term and the implication for external cephalic version. Ultrasound Obstet Gynecol 2006; 28:483.</a></li><li><a class="nounderline abstract_t">Boujenah J, Fleury C, Pharisien I, et al. [Cord accident after external cephalic version: Reality or mostly myth?]. Gynecol Obstet Fertil Senol 2017; 45:9.</a></li><li><a class="nounderline abstract_t">Suyama F, Ogawa K, Tazaki Y, et al. The outcomes and risk factors of fetal bradycardia associated with external cephalic version. J Matern Fetal Neonatal Med 2019; 32:922.</a></li><li><a class="nounderline abstract_t">Holmes WR, Hofmeyr GJ. Management of breech presentation in areas with high prevalence of HIV infection. Int J Gynaecol Obstet 2004; 87:272.</a></li><li><a class="nounderline abstract_t">External Cephalic Version: ACOG Practice Bulletin, Number 221. Obstet Gynecol 2020; 135:e203. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">Impey ORE, Greenwood CEL, Impey LWM. External cephalic version after previous cesarean section: A cohort study of 100 consecutive attempts. Eur J Obstet Gynecol Reprod Biol 2018; 231:210.</a></li><li><a class="nounderline abstract_t">McLaren RA Jr, Atallah F, Fisher N, Minkoff H. Maternal and Neonatal Outcomes after Attempted External Cephalic Version among Women with One Previous Cesarean Delivery. AJP Rep 2018; 8:e349.</a></li><li><a class="nounderline abstract_t">Homafar M, Gerard J, Turrentine M. Vaginal Delivery After External Cephalic Version in Patients With a Previous Cesarean Delivery: A Systematic Review and Meta-analysis. Obstet Gynecol 2020; 136:965.</a></li><li><a class="nounderline abstract_t">Zhang N, Ward H. Safety and efficacy of external cephalic version after a previous caesarean delivery: A systematic review. Aust N Z J Obstet Gynaecol 2021; 61:650.</a></li><li><a class="nounderline abstract_t">Devold Pay AS, Johansen K, Staff AC, et al. Effects of external cephalic version for breech presentation at or near term in high-resource settings: A systematic review of randomized and non-randomized studies. Eur J Midwifery 2020; 4:44.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ, Kulier R, West HM. External cephalic version for breech presentation at term. Cochrane Database Syst Rev 2015; :CD000083.</a></li><li><a class="nounderline abstract_t">de Hundt M, Velzel J, de Groot CJ, et al. Mode of delivery after successful external cephalic version: a systematic review and meta-analysis. Obstet Gynecol 2014; 123:1327.</a></li><li><a class="nounderline abstract_t">Vézina Y, Bujold E, Varin J, et al. Cesarean delivery after successful external cephalic version of breech presentation at term: a comparative study. Am J Obstet Gynecol 2004; 190:763.</a></li><li><a class="nounderline abstract_t">El-Toukhy T, Ramadan G, Maidman D, et al. Impact of parity on obstetric and neonatal outcome of external cephalic version. J Obstet Gynaecol 2007; 27:580.</a></li><li><a class="nounderline abstract_t">Krueger S, Simioni J, Griffith LE, et al. Labour Outcomes After Successful External Cephalic Version Compared With Spontaneous Cephalic Version. J Obstet Gynaecol Can 2018; 40:61.</a></li><li><a class="nounderline abstract_t">Tan JM, Macario A, Carvalho B, et al. Cost-effectiveness of external cephalic version for term breech presentation. BMC Pregnancy Childbirth 2010; 10:3.</a></li><li><a class="nounderline abstract_t">Gifford DS, Keeler E, Kahn KL. Reductions in cost and cesarean rate by routine use of external cephalic version: a decision analysis. Obstet Gynecol 1995; 85:930.</a></li><li><a class="nounderline abstract_t">Stokholm J, Thorsen J, Chawes BL, et al. Cesarean section changes neonatal gut colonization. J Allergy Clin Immunol 2016; 138:881.</a></li><li><a class="nounderline abstract_t">Black M, Bhattacharya S, Philip S, et al. Planned cesarean delivery at term and adverse outcomes in childhood health. JAMA 2015; 314:2271.</a></li><li><a class="nounderline abstract_t">Kristensen K, Henriksen L. Cesarean section and disease associated with immune function. J Allergy Clin Immunol 2016; 137:587.</a></li><li><a class="nounderline abstract_t">Kapellou O. Effect of caesarean section on brain maturation. Acta Paediatr 2011; 100:1416.</a></li><li><a class="nounderline abstract_t">Collins S, Ellaway P, Harrington D, et al. The complications of external cephalic version: results from 805 consecutive attempts. BJOG 2007; 114:636.</a></li><li><a class="nounderline abstract_t">Dahl CM, Zhang Y, Ong JX, et al. Patient characteristics associated with complications of external cephalic version. Am J Obstet Gynecol MFM 2021; 3:100411.</a></li><li><a class="nounderline abstract_t">Nassar N, Roberts CL, Barratt A, et al. Systematic review of adverse outcomes of external cephalic version and persisting breech presentation at term. Paediatr Perinat Epidemiol 2006; 20:163.</a></li><li><a class="nounderline abstract_t">Collaris RJ, Oei SG. External cephalic version: a safe procedure? A systematic review of version-related risks. Acta Obstet Gynecol Scand 2004; 83:511.</a></li><li><a class="nounderline abstract_t">Rijnders M, Herschderfer K, Prins M, et al. A retrospective study of the success, safety and effectiveness of external cephalic version without tocolysis in a specialised midwifery centre in the Netherlands. Midwifery 2008; 24:38.</a></li><li><a class="nounderline abstract_t">Rosman AN, Vlemmix F, Fleuren MA, et al. Patients' and professionals' barriers and facilitators to external cephalic version for breech presentation at term, a qualitative analysis in the Netherlands. Midwifery 2014; 30:324.</a></li><li><a class="nounderline abstract_t">Wastlund D, Moraitis AA, Dacey A, et al. Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis. PLoS Med 2019; 16:e1002778.</a></li><li><a class="nounderline abstract_t">Salim I, Staines-Urias E, Mathewlynn S, et al. The impact of a routine late third trimester growth scan on the incidence, diagnosis, and management of breech presentation in Oxfordshire, UK: A cohort study. PLoS Med 2021; 18:e1003503.</a></li><li><a class="nounderline abstract_t">Rosman AN, Guijt A, Vlemmix F, et al. Contraindications for external cephalic version in breech position at term: a systematic review. Acta Obstet Gynecol Scand 2013; 92:137.</a></li><li><a class="nounderline abstract_t">Felder L, McCurdy R, Berghella V. External cephalic version of the non-cephalic presenting twin: a systematic review. J Matern Fetal Neonatal Med 2022; 35:1712.</a></li><li><a class="nounderline abstract_t">Hinkson L, Schauer M, Latartara E, et al. The Charité external cephalic version for leading twin breech without regional anesthesia and tocolysis. A prospective study on feasibility, sonographic assessment and outcomes. Eur J Obstet Gynecol Reprod Biol 2022; 268:62.</a></li><li><a class="nounderline abstract_t">Aviram A, Barrett JFR, Melamed N, Mei-Dan E. Mode of delivery in multiple pregnancies. Am J Obstet Gynecol MFM 2022; 4:100470.</a></li><li><a class="nounderline abstract_t">Saling E, Müller-Holve W. External cephalic version under tocolysis. J Perinat Med 1975; 3:115.</a></li><li><a class="nounderline abstract_t">Ben-Meir A, Elram T, Tsafrir A, et al. The incidence of spontaneous version after failed external cephalic version. Am J Obstet Gynecol 2007; 196:157.e1.</a></li><li class="breakAll">https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg20a/ (Accessed on June 13, 2017).</li><li><a class="nounderline abstract_t">Hutton EK, Hofmeyr GJ, Dowswell T. External cephalic version for breech presentation before term. Cochrane Database Syst Rev 2015; :CD000084.</a></li><li><a class="nounderline abstract_t">Hutton EK, Hannah ME, Ross SJ, et al. The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG 2011; 118:564.</a></li><li><a class="nounderline abstract_t">Chenia F, Crowther CA. Does advice to assume the knee-chest position reduce the incidence of breech presentation at delivery? A randomized clinical trial. Birth 1987; 14:75.</a></li><li class="breakAll">Elkins VH. Procedure for turning breech. In: Effectiveness and satisfaction in antenatal care, Enkin M, Chalmers I (Eds), Spastic International Medical Publishers, London 1982. p.216.</li><li><a class="nounderline abstract_t">Bung P, Huch R, Huch A. [Is Indian version a successful method for decreasing the incidence of breech presentation?]. Geburtshilfe Frauenheilkd 1987; 47:202.</a></li><li><a class="nounderline abstract_t">Shinmura H, Matsushima T, Okuda N, et al. Cephalic version by postural management in the lateral position without the knee-chest position for primiparous breech presentation: A retrospective cohort study. J Obstet Gynaecol Res 2022; 48:703.</a></li><li><a class="nounderline abstract_t">de Wolff MG, Ladekarl M, Sparholt L, Lykke JA. Rebozo and External Cephalic Version in breech presentation (RECEIVE): A randomised controlled study. BJOG 2022; 129:1666.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ, Kulier R. Cephalic version by postural management for breech presentation. Cochrane Database Syst Rev 2012; 10:CD000051.</a></li><li><a class="nounderline abstract_t">Coyle ME, Smith C, Peat B. Cephalic version by moxibustion for breech presentation. Cochrane Database Syst Rev 2023; 5:CD003928.</a></li><li><a class="nounderline abstract_t">Nassar N, Roberts CL, Raynes-Greenow CH, et al. Evaluation of a decision aid for women with breech presentation at term: a randomised controlled trial [ISRCTN14570598]. BJOG 2007; 114:325.</a></li><li class="breakAll">www.biomedcentral.com/1471-2393/4/26 (Accessed on October 29, 2008).</li><li class="breakAll">Royal College of Obstetricians and Gynaecologists (RCOG). External cephalic version and reducing the incidence of breech presentation. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2006 Dec.</li><li><a class="nounderline abstract_t">Wilson RD, Caughey AB, Wood SL, et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol 2018; 219:523.e1.</a></li><li><a class="nounderline abstract_t">Skupski DW, Ghidini A. External Cephalic Version: Some Tricks of the Trade. Birth 2016; 43:189.</a></li><li class="breakAll">Reproductive Health Library. External cephalic version: Why and How? https://www.youtube.com/watch?v=fKaNZfUno50 (Accessed on February 08, 2021).</li><li><a class="nounderline abstract_t">Sánchez-Romero J, García-Soria V, Araico-Rodríguez F, et al. External Cephalic Version: Is it an Effective and Safe Procedure? J Vis Exp 2020.</a></li><li class="breakAll">Catharina Ziekenhuis Teaching Hospital. External Cephalic Version. https://www.youtube.com/watch?v=aWTmxPV15DI (Accessed on February 08, 2021).</li><li><a class="nounderline abstract_t">Burr R, Helyer P, Robson SC. A training model for external cephalic version. Eur J Obstet Gynecol Reprod Biol 2001; 99:199.</a></li><li><a class="nounderline abstract_t">Baaklini C, Menassa N, Larios JT, Ballas DA. A Simulation Model for External Cephalic Version. Cureus 2020; 12:e12382.</a></li><li><a class="nounderline abstract_t">Keriakos R, Abdelmalek B, Campbell L. Sheffield modified technique for external cephalic version. J Obstet Gynaecol 2009; 29:384.</a></li><li class="breakAll">Hofmeyr GJ. Breech presentation and abnormal lie in late pregnancy. In: Effective Care in Pregnancy and Childbirth, Chalmers I, Enkin MW, Keirse MJNC (Eds), Oxford University Press, Oxford 1989. p.653.</li><li><a class="nounderline abstract_t">Vallikkannu N, Nadzratulaiman WN, Omar SZ, et al. Talcum powder or aqueous gel to aid external cephalic version: a randomised controlled trial. BMC Pregnancy Childbirth 2014; 14:49.</a></li><li><a class="nounderline abstract_t">Hutton EK, Kaufman K, Hodnett E, et al. External cephalic version beginning at 34 weeks' gestation versus 37 weeks' gestation: a randomized multicenter trial. Am J Obstet Gynecol 2003; 189:245.</a></li><li><a class="nounderline abstract_t">Impey L, Pandit M. Tocolysis for repeat external cephalic version in breech presentation at term: a randomised, double-blinded, placebo-controlled trial. BJOG 2005; 112:627.</a></li><li><a class="nounderline abstract_t">Ducarme G. [Breech Presentation: CNGOF Guidelines for Clinical Practice - External Cephalic Version and other Interventions to turn Breech Babies to Cephalic Presentation]. Gynecol Obstet Fertil Senol 2020; 48:81.</a></li><li><a class="nounderline abstract_t">Cluver C, Gyte GM, Sinclair M, et al. Interventions for helping to turn term breech babies to head first presentation when using external cephalic version. Cochrane Database Syst Rev 2015; :CD000184.</a></li><li><a class="nounderline abstract_t">Velzel J, Vlemmix F, Opmeer BC, et al. Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial. BMJ 2017; 356:i6773.</a></li><li><a class="nounderline abstract_t">Belfort MA. Intravenous nitroglycerin as a tocolytic agent for intrapartum external cephalic version. S Afr Med J 1993; 83:656.</a></li><li><a class="nounderline abstract_t">Andarsio, F, Feng, TI. External cephalic version: nitroglycerin versus terbutaline. Am J Obstet Gynecol 2000; 182:161.</a></li><li><a class="nounderline abstract_t">Yanny H, Johanson R, Balwin KJ, et al. Double-blind randomised controlled trial of glyceryl trinitrate spray for external cephalic version. BJOG 2000; 107:562.</a></li><li><a class="nounderline abstract_t">Bujold E, Marquette GP, Ferreira E, et al. Sublingual nitroglycerin versus intravenous ritodrine as tocolytic for external cephalic version: a double-blinded randomized trial. Am J Obstet Gynecol 2003; 188:1454.</a></li><li><a class="nounderline abstract_t">Bujold E, Boucher M, Rinfret D, et al. Sublingual nitroglycerin versus placebo as a tocolytic for external cephalic version: a randomized controlled trial in parous women. Am J Obstet Gynecol 2003; 189:1070.</a></li><li><a class="nounderline abstract_t">Morgan PJ, Kung R, Tarshis J. Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002; 24:403.</a></li><li><a class="nounderline abstract_t">Hilton J, Allan B, Swaby C, et al. Intravenous nitroglycerin for external cephalic version: a randomized controlled trial. Obstet Gynecol 2009; 114:560.</a></li><li><a class="nounderline abstract_t">Katz D, Riley K, Kim E, Beilin Y. Comparison of Nitroglycerin and Terbutaline for External Cephalic Version in Women Who Received Neuraxial Anesthesia: A Retrospective Analysis. Anesth Analg 2020; 130:e58.</a></li><li><a class="nounderline abstract_t">Wilcox CB, Nassar N, Roberts CL. Effectiveness of nifedipine tocolysis to facilitate external cephalic version: a systematic review. BJOG 2011; 118:423.</a></li><li><a class="nounderline abstract_t">Yamasato K, Kaneshiro B, Salcedo J. Neuraxial blockade for external cephalic version: Cost analysis. J Obstet Gynaecol Res 2015; 41:1023.</a></li><li><a class="nounderline abstract_t">Magro-Malosso ER, Saccone G, Di Tommaso M, et al. Neuraxial analgesia to increase the success rate of external cephalic version: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2016; 215:276.</a></li><li><a class="nounderline abstract_t">Carvalho B, Tan JM, Macario A, et al. Brief report: a cost analysis of neuraxial anesthesia to facilitate external cephalic version for breech fetal presentation. Anesth Analg 2013; 117:155.</a></li><li><a class="nounderline abstract_t">Johnson RL, Elliott JP. Fetal acoustic stimulation, an adjunct to external cephalic version: a blinded, randomized crossover study. Am J Obstet Gynecol 1995; 173:1369.</a></li><li><a class="nounderline abstract_t">Bénifla JL, Goffinet F, Bascou V, et al. [Transabdominal amnio-infusion facilitates external version maneuver after initial failure. Six successful attempts]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:319.</a></li><li><a class="nounderline abstract_t">Adama van Scheltema PN, Feitsma AH, Middeldorp JM, et al. Amnioinfusion to facilitate external cephalic version after initial failure. Obstet Gynecol 2006; 108:591.</a></li><li><a class="nounderline abstract_t">Diguisto C, Winer N, Descriaud C, et al. Amnioinfusion for women with a singleton breech presentation and a previous failed external cephalic version: a randomized controlled trial. J Matern Fetal Neonatal Med 2018; 31:993.</a></li><li><a class="nounderline abstract_t">Burgos J, Quintana E, Cobos P, et al. Effect of maternal intravenous fluid therapy on external cephalic version at term: a prospective cohort study. Am J Obstet Gynecol 2014; 211:665.e1.</a></li><li><a class="nounderline abstract_t">Zobbi VF, Nespoli A, Spreafico E, et al. Effect of Oral Hydration on External Cephalic Version at Term. J Obstet Gynecol Neonatal Nurs 2017; 46:686.</a></li><li><a class="nounderline abstract_t">Burgos J, Cobos P, Osuna C, et al. Nitrous oxide for analgesia in external cephalic version at term: prospective comparative study. J Perinat Med 2013; 41:719.</a></li><li><a class="nounderline abstract_t">Straube LE, Fardelmann KL, Penwarden AA, et al. Nitrous oxide analgesia for external cephalic version: A randomized controlled trial. J Clin Anesth 2021; 68:110073.</a></li><li><a class="nounderline abstract_t">Massalha M, Izhaki I, Iskander R, Salim R. Effect of nitrous oxide use on external cephalic version success rate; a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022; 35:9702.</a></li><li><a class="nounderline abstract_t">Lomas S, Minton Z, Daniels JP. Systematic review of the effectiveness of remifentanil in term breech pregnancies undergoing external cephalic version. Int J Obstet Anesth 2023; 54:103649.</a></li><li><a class="nounderline abstract_t">Guittier MJ, Guillemin F, Farinelli EB, et al. Hypnosis for the control of pain associated with external cephalic version: a comparative study. J Altern Complement Med 2013; 19:820.</a></li><li><a class="nounderline abstract_t">Reinhard J, Heinrich TM, Reitter A, et al. Clinical hypnosis before external cephalic version. Am J Clin Hypn 2012; 55:184.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ, Sonnendecker EW. Cardiotocographic changes after external cephalic version. Br J Obstet Gynaecol 1983; 90:914.</a></li><li><a class="nounderline abstract_t">Kuppens SM, Smailbegovic I, Houterman S, et al. Fetal heart rate abnormalities during and after external cephalic version: Which fetuses are at risk and how are they delivered? BMC Pregnancy Childbirth 2017; 17:363.</a></li><li><a class="nounderline abstract_t">Hruban L, Janků P, Jordanova K, et al. The effect of transient fetal bradycardia and other heart rate changes during and after external cephalic version on perinatal outcomes. Eur J Obstet Gynecol Reprod Biol 2020; 245:39.</a></li><li><a class="nounderline abstract_t">Lemaitre J, Planche L, Ducarme G. Systematic Kleihauer-Betke Test after External Cephalic Version for Breech Presentation: Is It Useful? J Clin Med 2020; 9.</a></li><li><a class="nounderline abstract_t">Boucher M, Marquette GP, Varin J, et al. Fetomaternal hemorrhage during external cephalic version. Obstet Gynecol 2008; 112:79.</a></li><li><a class="nounderline abstract_t">Khoo CL, Bollapragada S, Mackenzie F. Massive fetomaternal hemorrhage following failed external cephalic version: case report. J Perinat Med 2006; 34:250.</a></li><li><a class="nounderline abstract_t">Shankar M, Gough GW, Chakravarti S, Vellacott ID. Massive feto-maternal haemorrhage with good perinatal outcome following failed external cephalic version. Fetal Diagn Ther 2004; 19:68.</a></li><li><a class="nounderline abstract_t">Burgos J, Iglesias M, Pijoan JI, et al. Probability of cesarean delivery after successful external cephalic version. Int J Gynaecol Obstet 2015; 131:192.</a></li><li><a class="nounderline abstract_t">de Hundt M, Vlemmix F, Bais JM, et al. Risk factors for cesarean section and instrumental vaginal delivery after successful external cephalic version. J Matern Fetal Neonatal Med 2016; 29:2005.</a></li><li><a class="nounderline abstract_t">Ben-Meir A, Elram T, Tsafrir A, et al. The incidence of spontaneous version after failed external cephalic version. Am J Obstet Gynecol 2007; 196:157.e1.</a></li><li><a class="nounderline abstract_t">Kaneti H, Rosen D, Markov S, et al. Intrapartum external cephalic version of footling-breech presentation. Acta Obstet Gynecol Scand 2000; 79:1083.</a></li><li><a class="nounderline abstract_t">Ferguson JE 2nd, Dyson DC. Intrapartum external cephalic version. Am J Obstet Gynecol 1985; 152:297.</a></li></ol></div><div id="topicVersionRevision">Topic 6779 Version 71.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18978117" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : External cephalic version-related risks: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30223309" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : External cephalic version at term: a cohort study of 18 years' experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36649361" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : External cephalic version success rate and associated factors: Experience from a tertiary center in Sub-Saharan Africa: A cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36796109" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Predictive factors for successful external cephalic version with regional anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36068364" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Factors influencing the effect of external cephalic version: a retrospective nationwide cohort analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6743606" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A randomized trial of external cephalic version with tocolysis in late pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3514545" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Impact of a protocol for external cephalic version under tocolysis at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18828059" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prognostic parameters for successful external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32779362" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prediction model of success for external cephalic version. Complications and perinatal outcomes after a successful version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7056507" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Ultrasonic examination before external version of breech presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3942700" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : External cephalic version and spontaneous version rates: ethnic and other determinants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26437955" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Predictors for a successful external cephalic version: a single centre experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3288930" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : External cephalic version with tocolysis: factors associated with success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14526307" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The relationship between amniotic fluid index and successful external cephalic version: a 14-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18456227" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical factors to predict the outcome of external cephalic version: a metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19032661" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Successful but limited use of external cephalic version in Auckland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3881123" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Spontaneous cephalic version of breech presentation in the last trimester.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2193517" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Ultrasonography and external cephalic version at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Die Ausere wendung de Feten aus beckenendlage Schadellage in Terminnale unter Tokolyse</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2692178" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A prospective randomised controlled trial of external cephalic version comparing two methods of uterine tocolysis with a non-tocolysis group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3940340" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Antepartum external cephalic version under tocolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29355061" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The impact of maternal body mass index on external cephalic version success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34622950" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Success rate of external cephalic version in relation to the woman's body mass index and other factors-a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33416280" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Association of Persistent Breech Presentation With External Cephalic Version Success.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21934456" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Ultrasonographic evaluation of myometrial thickness and prediction of a successful external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9236644" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Predictors of successful external cephalic version at term: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6342657" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of external cephalic version in late pregnancy on breech presentation and caesarean section rate: a controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1998637" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : External cephalic version at term. A randomized controlled trial using tocolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30965185" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Introduction of a dedicated team increases the success rate of external cephalic version: A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37247646" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Role of individual physicians in success of external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19115237" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Ultrasound factors to predict the outcome of external cephalic version: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20132565" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : [Fewer breech deliveries after implementation of a modified cephalic version protocol].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30969207" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prediction of Success in External Cephalic Version for Breech Presentation at Term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19642040" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Does fetal weight estimated by ultrasound really affect the success rate of external cephalic version?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : OP11.02: Nuchal cords in breech presentation at term and the implication for external cephalic version</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28238321" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : [Cord accident after external cephalic version: Reality or mostly myth?]</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29057691" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The outcomes and risk factors of fetal bradycardia associated with external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15548407" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Management of breech presentation in areas with high prevalence of HIV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32332415" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : External Cephalic Version: ACOG Practice Bulletin, Number 221.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30412904" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : External cephalic version after previous cesarean section: A cohort study of 100 consecutive attempts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30574429" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Maternal and Neonatal Outcomes after Attempted External Cephalic Version among Women with One Previous Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33030882" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Vaginal Delivery After External Cephalic Version in Patients With a Previous Cesarean Delivery: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34169515" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Safety and efficacy of external cephalic version after a previous caesarean delivery: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33537645" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effects of external cephalic version for breech presentation at or near term in high-resource settings: A systematic review of randomized and non-randomized studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25828903" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : External cephalic version for breech presentation at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24807332" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Mode of delivery after successful external cephalic version: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15042011" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cesarean delivery after successful external cephalic version of breech presentation at term: a comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17896255" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Impact of parity on obstetric and neonatal outcome of external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28780214" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Labour Outcomes After Successful External Cephalic Version Compared With Spontaneous Cephalic Version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20092630" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Cost-effectiveness of external cephalic version for term breech presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7770262" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Reductions in cost and cesarean rate by routine use of external cephalic version: a decision analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27045582" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Cesarean section changes neonatal gut colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26624826" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Planned cesarean delivery at term and adverse outcomes in childhood health</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26371844" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cesarean section and disease associated with immune function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21781159" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of caesarean section on brain maturation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17355270" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The complications of external cephalic version: results from 805 consecutive attempts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34058425" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Patient characteristics associated with complications of external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16466434" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Systematic review of adverse outcomes of external cephalic version and persisting breech presentation at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15144330" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : External cephalic version: a safe procedure? A systematic review of version-related risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17196716" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A retrospective study of the success, safety and effectiveness of external cephalic version without tocolysis in a specialised midwifery centre in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23664312" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Patients' and professionals' barriers and facilitators to external cephalic version for breech presentation at term, a qualitative analysis in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30990808" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33449926" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The impact of a routine late third trimester growth scan on the incidence, diagnosis, and management of breech presentation in Oxfordshire, UK: A cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22994660" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Contraindications for external cephalic version in breech position at term: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32434414" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : External cephalic version of the non-cephalic presenting twin: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34871953" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The Charitéexternal cephalic version for leading twin breech without regional anesthesia and tocolysis. A prospective study on feasibility, sonographic assessment and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34454159" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Mode of delivery in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1185481" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : External cephalic version under tocolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17306662" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The incidence of spontaneous version after failed external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17306662" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The incidence of spontaneous version after failed external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26222245" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : External cephalic version for breech presentation before term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21291506" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3311064" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Does advice to assume the knee-chest position reduce the incidence of breech presentation at delivery? A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3311064" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Does advice to assume the knee-chest position reduce the incidence of breech presentation at delivery? A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3582928" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : [Is Indian version a successful method for decreasing the incidence of breech presentation?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34994031" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Cephalic version by postural management in the lateral position without the knee-chest position for primiparous breech presentation: A retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35114058" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Rebozo and External Cephalic Version in breech presentation (RECEIVE): A randomised controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23076882" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Cephalic version by postural management for breech presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37158339" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Cephalic version by moxibustion for breech presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17217360" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Evaluation of a decision aid for women with breech presentation at term: a randomised controlled trial [ISRCTN14570598].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17217360" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Evaluation of a decision aid for women with breech presentation at term: a randomised controlled trial [ISRCTN14570598].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17217360" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Evaluation of a decision aid for women with breech presentation at term: a randomised controlled trial [ISRCTN14570598].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30240657" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27534513" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : External Cephalic Version: Some Tricks of the Trade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27534513" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : External Cephalic Version: Some Tricks of the Trade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32568226" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : External Cephalic Version: Is it an Effective and Safe Procedure?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32568226" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : External Cephalic Version: Is it an Effective and Safe Procedure?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11788171" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A training model for external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33527060" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A Simulation Model for External Cephalic Version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19603313" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Sheffield modified technique for external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19603313" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Sheffield modified technique for external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24468078" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Talcum powder or aqueous gel to aid external cephalic version: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12861170" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : External cephalic version beginning at 34 weeks' gestation versus 37 weeks' gestation: a randomized multicenter trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15842288" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Tocolysis for repeat external cephalic version in breech presentation at term: a randomised, double-blinded, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31678503" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : [Breech Presentation: CNGOF Guidelines for Clinical Practice - External Cephalic Version and other Interventions to turn Breech Babies to Cephalic Presentation].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25674710" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Interventions for helping to turn term breech babies to head first presentation when using external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28126898" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8310358" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Intravenous nitroglycerin as a tocolytic agent for intrapartum external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : External cephalic version: nitroglycerin versus terbutaline</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10759280" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Double-blind randomised controlled trial of glyceryl trinitrate spray for external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12824978" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Sublingual nitroglycerin versus intravenous ritodrine as tocolytic for external cephalic version: a double-blinded randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14586357" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Sublingual nitroglycerin versus placebo as a tocolytic for external cephalic version: a randomized controlled trial in parous women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12196860" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Nitroglycerin as a uterine relaxant: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19701035" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Intravenous nitroglycerin for external cephalic version: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30985380" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Comparison of Nitroglycerin and Terbutaline for External Cephalic Version in Women Who Received Neuraxial Anesthesia: A Retrospective Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21199292" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Effectiveness of nifedipine tocolysis to facilitate external cephalic version: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25771920" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Neuraxial blockade for external cephalic version: Cost analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27131581" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Neuraxial analgesia to increase the success rate of external cephalic version: a systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23592608" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Brief report: a cost analysis of neuraxial anesthesia to facilitate external cephalic version for breech fetal presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7503169" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Fetal acoustic stimulation, an adjunct to external cephalic version: a blinded, randomized crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7622781" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : [Transabdominal amnio-infusion facilitates external version maneuver after initial failure. Six successful attempts].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16946219" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Amnioinfusion to facilitate external cephalic version after initial failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28279119" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Amnioinfusion for women with a singleton breech presentation and a previous failed external cephalic version: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24949536" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Effect of maternal intravenous fluid therapy on external cephalic version at term: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28806537" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Effect of Oral Hydration on External Cephalic Version at Term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23924521" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Nitrous oxide for analgesia in external cephalic version at term: prospective comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33017784" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Nitrous oxide analgesia for external cephalic version: A randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35282744" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Effect of nitrous oxide use on external cephalic version success rate; a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36989876" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Systematic review of the effectiveness of remifentanil in term breech pregnancies undergoing external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23461523" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Hypnosis for the control of pain associated with external cephalic version: a comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23189523" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Clinical hypnosis before external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6626491" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Cardiotocographic changes after external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29041923" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Fetal heart rate abnormalities during and after external cephalic version: Which fetuses are at risk and how are they delivered?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31838399" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : The effect of transient fetal bradycardia and other heart rate changes during and after external cephalic version on perinatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32629792" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Systematic Kleihauer-Betke Test after External Cephalic Version for Breech Presentation: Is It Useful?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18591311" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Fetomaternal hemorrhage during external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16602849" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Massive fetomaternal hemorrhage following failed external cephalic version: case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14646421" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Massive feto-maternal haemorrhage with good perinatal outcome following failed external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26294171" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Probability of cesarean delivery after successful external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26333291" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Risk factors for cesarean section and instrumental vaginal delivery after successful external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17306662" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : The incidence of spontaneous version after failed external cephalic version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11130092" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Intrapartum external cephalic version of footling-breech presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4003475" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Intrapartum external cephalic version.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
